This inventor holds 10 USPTO granted patents and 3 published patent applications, plus 4 CIPO patents and 6 EPO patents. Top assignees: Msd K.k., Banyu Pharmaceutical Co. Ltd, Taiho Pharmaceutical Company Limited. Active years: 2010-2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Tsukuba, JP (2010 - 2014)
- Ibaraki, JP (2013 - 2023)
Company Filing History:
5 out of 47 
2 out of 237 
2 out of 320 
Years Active: 2010-2023
Title: **Fuyuki Yamamoto: A Pioneer in Pharmaceutical Innovation**
Introduction
Fuyuki Yamamoto, hailing from Tsukuba, Japan, is an accomplished inventor known for his significant contributions to the field of pharmaceuticals. With a remarkable portfolio of 10 patents, he has established himself as a key player in developing innovative compounds for therapeutic applications.
Latest Patents
Among his latest innovations, Yamamoto has developed substituted pyrrolo[2,3-d]pyrimidines as EGFR inhibitors. This novel compound is designed to inhibit the epidermal growth factor receptor (EGFR) or its salts, thus presenting potential therapeutic benefits. Another notable invention is the 5H-pyrrolo[2,3-D]pyrimidin-6(7H)-one derivative. This compound showcases inhibitory activity against various kinases, including Akt kinase, Rsk kinase, and S6K kinase. It holds promise as a therapeutic agent for diseases related to these kinases, particularly in cancer treatment.
Career Highlights
Yamamoto's career is marked by his associations with prominent companies in the pharmaceutical sector, such as MSD K.K. and Banyu Pharmaceutical Co. Ltd. His work has been impactful, contributing to the development of groundbreaking treatments that address significant health challenges.
Collaborations
Throughout his career, Fuyuki Yamamoto has collaborated with talented colleagues, including Toshihiro Sakamoto and Hidetomo Furuyama. These partnerships have amplified his research efforts and led to the successful development of pivotal pharmaceutical innovations.
Conclusion
Fuyuki Yamamoto stands out as a leading inventor in the realm of pharmaceuticals. His extensive patent portfolio and dedication to addressing critical health issues underscore his importance in fostering continued advancements in medical science. Through his work, Yamamoto not only furthers drug development but also inspires the next generation of inventors and researchers.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile